Best Addiction and Substance Abuse Grants in Delaware

Delaware Division of Substance Abuse and Mental Health

The Delaware Division of Substance Abuse and Mental Health (DSAMH) recognizes the need to leverage local community expertise to reach and impact the wide array of communities that continue to be impacted by the opioid overdose crisis. DSAMH also acknowledges that not all communities have been or are impacted equally. Although there have been recent improvements in drug overdose deaths, significant work remains. DSAMH is committed to offering multiple ways to partner with communities to prevent overdose, reduce the impact of opioid and stimulant use disorders, and improve access to prevention, treatment, and recovery services across Delaware.

ECASU Community Awareness Partnerships

Through the federal State Opioid Response (SOR) Grant, the Engaging Communities in Addressing Substance Use (ECASU) initiative offers three opportunities for organizations and community leaders working to address OUD/STUD in Delaware:

• Messaging Campaigns (ECASU-MC)
• Mini-Grants (ECASU-MG)
• Community Awareness Partnerships (ECASU-CP)
  • The ECASU Community Awareness Partnerships (ECASU-CP) provide technical assistance to community-based, grassroots, advocacy, faith-based organizations, community coalitions, community leaders, and treatment providers (collectively referred to as Community Partners) to directly engage members of the community to educate, increase awareness, and provide resources for OUD/STUD. These strategies can include, but are not limited to, in-person events, educational sessions, social media strategies, video campaigns, and listening sessions. Below are the focus areas of DSAMH’s current campaign strategies, which require a focus on opioid and stimulant use, that can be supported by DSAMH and its technical assistance vendors for partners to refine and implement within their own communities.
    • Reduced stigma toward persons with OUD/STUD
    • Promoting awareness of and access to OUD/STUD treatment and recovery services
    • Reducing stigma toward medications for opioid use disorders, such as methadone and buprenorphine
    • Promoting access to naloxone/Narcan
    • Increasing awareness and knowledge of existing resources among local communities 

Delaware Division of Substance Abuse and Mental Health

The Delaware Division of Substance Abuse and Mental Health (DSAMH) recognizes the need to leverage local community expertise to reach and impact the wide array of communities that continue to be impacted by the opioid overdose crisis. DSAMH also acknowledges that not all communities have been or are impacted equally. Although there have been recent improvements in drug overdose deaths, significant work remains. DSAMH is committed to offering multiple ways to partner with communities to prevent overdose, reduce the impact of opioid and stimulant use disorders, and improve access to prevention, treatment, and recovery services across Delaware.

ECASU Mini-Grants

Through the federal State Opioid Response (SOR) Grant, the Engaging Communities in Addressing Substance Use (ECASU) initiative offers three opportunities for organizations and community leaders working to address OUD/STUD in Delaware:

• Community Awareness Partnerships (ECASU-CP)
• Messaging Campaigns (ECASU-MC)
• Mini-Grants (ECASU-MG)
• The ECASU Mini-Grants (ECASU-MG) provide direct funding to community-based organizations (CBOs) to support and engage local communities in Delaware who are impacted by OUD/STUD. This funding opportunity will be administered by vendor partner Bowling Business Strategies (BBS) on behalf of DSAMH to provide direct funding to selected CBOs. 
• ECASU-MG projects must be aligned with DSAMH’s SOR and ECASU goals of improving the system of care for all Delawareans with, or at risk for, OUD/STUD, with particular emphasis on one or more of the following populations:
  • Pregnant and parenting people
  • Veterans
  • People living in high-need zip codes (including rural communities)
  • People involved in the justice system
  • School-aged youth 

Delaware Division of Substance Abuse and Mental Health

The Delaware Division of Substance Abuse and Mental Health (DSAMH) recognizes the need to leverage local community expertise to reach and impact the wide array of communities that continue to be impacted by the opioid overdose crisis. DSAMH also acknowledges that not all communities have been or are impacted equally. Although there have been recent improvements in drug overdose deaths, significant work remains. DSAMH is committed to offering multiple ways to partner with communities to prevent overdose, reduce the impact of opioid and stimulant use disorders, and improve access to prevention, treatment, and recovery services across Delaware.

ECASU Messaging Campaigns

Through the federal State Opioid Response (SOR) Grant, the Engaging Communities in Addressing Substance Use (ECASU) initiative offers three opportunities for organizations and community leaders working to address OUD/STUD in Delaware:

• Community Awareness Partnerships (ECASU-CP)
• Mini-Grants (ECASU-MG)
• Messaging Campaigns (ECASU-MC)
  • Provides direct grant funding to organizations to develop and implement community-based communication, education, and awareness campaigns to address substance use awareness or stigma among local communities. ECASU-MC projects must align with at least one of the following goals: 
    • Increase awareness and deliver education related to OUD and STUD
    • Reduce stigma at local and broader levels throughout Delaware 

Nonprofit and local government organizations working on addiction and substance use disorders, alcoholism, or drug use disorder can apply for funding from the Confederated Tribes of Siletz Indians. Focused on addiction, the fund invites eligible Native American organizations nationwide and groups in its Oregon service counties to support prevention, treatment, housing, health, and related services.

Delaware research institutions and healthcare or community partners working on addiction and substance use disorders can access funding through the National Institutes of Health to test SBIRT/P approaches for adults facing health disparities. Projects must prospectively evaluate screening, brief intervention, and referral to treatment or prevention for alcohol, tobacco, and other drug use, leveraging healthcare and community collaborations.

Nonprofit 501(c)(3) organizations addressing childhood trauma, family healing, and health access in Delaware and other AmeriHealth Caritas Medicaid markets can apply for Amerihealth Caritas Foundation project grants of US $100,000 - US $150,000. Grants from Amerihealth Caritas Foundation help programs serving communities with high Medicaid enrollment, including addiction and substance use disorder initiatives for children and families.

Grants support research organizations testing SBIRT/P approaches to prevent and treat alcohol, tobacco, and other drug use among adults experiencing health disparities, including in Delaware. Grants from the National Institutes of Health help addiction and substance use programs collaborate with healthcare and community partners to prospectively evaluate screening, brief intervention, and referral to treatment or prevention.

The Opioid Crisis Response Program Fellowship, offered by Equal Justice Works, addresses the opioid epidemic by mobilizing public interest lawyers to provide vital civil legal aid to underserved communities affected by Opioid Use Disorder. This two-year fellowship enables attorney fellows to advocate for clients' rights, reduce barriers to treatment, and enhance community education about legal impacts. Through collaboration with various stakeholders, the program aims to improve health outcomes and foster systemic change in the fight against this public health crisis.

The HEAL Initiative offers Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01), targeting early career researchers and clinicians. This program emphasizes training in implementation science methods to tackle opioid use disorder and enhance recovery support services. By fostering expertise in these areas, the initiative aims to combat the overdose crisis and cultivate future leaders in addiction research and clinical practice.

This funding opportunity encourages Small Business Technology Transfer (STTR) grant applications focused on developing FDA-regulated medical products for patients with opioid and stimulant use disorders (OUD/StUD). The grant supports projects in pharmacotherapeutics and medical devices, including software as a medical device. It aims to address the national crisis by fostering innovative solutions that meet the needs of affected individuals and communities. Companies with promising technologies are invited to apply.

The National Cooperative Drug/Device Discovery/Development Groups (NCDDG) program invites applications to foster innovative research in treating mental disorders and substance use issues. This initiative promotes collaboration between academia and industry, supporting diverse, multidisciplinary projects aimed at developing rational therapies and neurostimulation techniques. Applicants are encouraged to submit Letters of Intent 30 days before the proposal deadline to enhance project alignment with funding goals.

The NCDDG program supports innovative research aiming to discover and develop new treatments for mental disorders, including substance use and alcohol use disorders. This initiative encourages collaborations between academic and industry partners to advance neurostimulation techniques and drug/device development. Applicants are invited to submit proposals that focus on specific projects utilizing the U01 mechanism, with a clear emphasis on rationally designed candidate agents and cutting-edge technologies. Letters of Intent are encouraged 30 days prior to the submission deadline.

The NIH R25 program aims to enhance inclusivity in the substance use and addiction research workforce by supporting educational activities for individuals from diverse backgrounds. This initiative focuses on skill development courses and research experiences, encouraging underrepresented groups to pursue careers in biomedical and behavioral sciences. By fostering an inclusive environment, the program seeks to promote diversity in research and improve outcomes in health-related fields. Applications are due by 5:00 PM local time, with optional Letters of Intent encouraged.

Clinician-scientist training programs in addiction and substance use disorders in Delaware and other eligible U.S. locations can access funding through the National Institutes of Health, with awards up to US $750,000 for K12 institutional career development. Grants support intensive, supervised research training that helps Scholars progress toward independent substance use and substance use disorder research careers.

Research institutions and teams conducting HIV and substance use disorder studies in Delaware and other U.S. jurisdictions can seek funding through the National Institutes of Health. Focused on high-priority HIV and substance use research, this opportunity supports projects from basic science to clinical and implementation research, with awards up to US $1,500,000.

Delaware addiction and substance use research institutions can access funding through the National Institutes of Health to study the harmful effects of acute exposure to ultra-potent synthetic opioids and combinations like fentanyl and xylazine. Eligible U.S. and territory-based researchers may receive up to US $1,500,000 for basic research on acute and longer-term pathophysiological impacts.

Clinically focused education programs on substance use and substance use disorders in Delaware and other U.S. jurisdictions can apply for up to US $350,000 to enhance clinician and clinical researcher training. Grants from the National Institutes of Health help organizations build research-focused education for current and future health service providers working in addiction and drug use disorder care.

Delaware research institutions and clinical trial teams focused on addiction and substance use disorders can access funding through the FDA to study analgesics, anesthetics, and related drug safety. Awards of US $2,000,000 support clinical trials and evidence-based plans to improve prescribing, outcome measures, and functional assessments in pain, addiction medicine, and anesthesia.

Research institutions and other eligible organizations can seek funding to study tobacco, alcohol, and cannabis policy impacts on health disparities in the U.S., including Delaware. US Dept. of Health & Human Services: National Institutes of Health supports projects up to Up to US $2,500,000 that engage communities and advance cancer prevention and health equity among affected populations.

Grants support U.S.-based research organizations studying how tobacco, alcohol, or cannabis policies affect use or secondhand exposure among populations experiencing health disparities. Grants from the National Institutes of Health help Delaware addiction and substance use disorder researchers conduct community-engaged studies that advance cancer prevention and promote health equity, with awards up to US $275,000.

Researchers and research institutions studying addiction and substance use disorders in Delaware and other U.S. jurisdictions can seek up to US $275,000 for time-sensitive pilot or exploratory projects. US Dept. of Health & Human Services: National Institutes of Health supports rapid-response studies on emerging drug issues, marijuana trends, prescription drug abuse, health system changes, and justice-related drug policy shifts.

The HEAL initiative focuses on translating addiction research into practice, targeting the opioid crisis and overdose events. It emphasizes action-oriented research to identify barriers and facilitators in substance use treatment and prevention. The initiative seeks effective and scalable approaches to implement evidence-based interventions across various care settings. Collaboration among experts in health economics, implementation science, and addiction recovery is encouraged to foster innovative solutions. This Notice of Funding Opportunity allows time for applicants to develop impactful projects.

Just One More Grant aims to transform lives by providing financial support to individuals and nonprofit organizations in the U.S. who are overcoming challenges like mental health issues, drug misuse, and educational barriers. The foundation encourages applications from those committed to personal growth and community support. Though current grants are paused for nonprofits, interested individuals with actionable plans are invited to apply. More information and past winners can be found on their website.

This NOFO invites applications for innovative research aimed at developing and implementing interventions to prevent and treat substance use disorders (SUDs) and overdose. It encourages studies that can rapidly advance candidate solutions towards regulatory approval or clinical use, while also addressing co-morbid SUDs. The initiative supports a wide range of research including basic, clinical, translational, and implementation strategies to tackle drug misuse and related health issues, such as HIV/AIDS.

The NIH is offering access to biospecimens from the ABCD, HBCD, and PATH studies to promote research on health and disease across a lifetime. This initiative encourages projects that utilize these samples to deepen understanding of genetic and environmental influences, particularly substance exposure. Researchers can submit proposals to maximize the scientific utility of these resources, in alignment with the goals outlined under federal health regulations.

The Residential Treatment for Pregnant and Postpartum Women program aims to deliver essential services to women facing substance use disorders. By offering comprehensive residential treatment options, the program supports both recovery and the well-being of mothers and their children. Funded by the Substance Abuse and Mental Health Services Administration, this initiative addresses the unique challenges of pregnant and postpartum women, ensuring they receive the care necessary for a successful recovery journey.

The Rural Opioid Technical Assistance Centers program aims to provide vital training and technical assistance to combat opioid and stimulant misuse in rural areas. With ten regional centers and a national coordinating office, the initiative focuses on high-quality prevention, treatment, and recovery support services for substance use disorders, including polysubstance use. The program anticipates awarding 11 new grants to enhance community support and reduce substance-related challenges.